top of page

Medical Device Regulations in China (NMPA)

Updated: Aug 3, 2023

China has become a leading force in the world of medical devices, thanks to its booming market and stringent regulatory measures aimed at guaranteeing the safety, effectiveness, and excellence of such devices. China's Medical Technology market is currently witnessing tremendous growth potential, with projections indicating a remarkable revenue surge to an impressive US$41.44 billion by the year 2023. Leading the charge within this expansive market is the Medical Devices sector, which is expected to achieve a substantial market volume of approximately US$31.45 billion during the same period.

  • Classification of Medical Devices:

As the Chinese government endeavours to ensure that medical devices within its jurisdiction are safe and effective, it has instituted a comprehensive classification system to categorize these devices according to their level of risk. This system segregates medical devices into three distinct categories, namely Class I, Class II, and Class III. Class I devices are deemed to have the least amount of risk, while Class III devices are seen as the most perilous. Classification within these categories has a profound impact on the regulatory requirements and procedures that manufacturers must follow during the registration process.

  • Regulatory Authorities:

It's no secret that the medical device industry in China is a highly regulated space, and the main regulatory authority responsible for making sure everything stays in line is none other than the National Medical Products Administration, otherwise known as the NMPA (formerly called the China Food and Drug Administration, or CFDA). This authoritative body takes its role seriously, overseeing everything from medical device registration to inspections and supervision.

  • Registration Process:

In order to market medical devices legally within China, manufacturers are required to obtain Medical device registration from the National Medical Products Administration (NMPA). This registration process comprises several intricate steps characterized by perplexity and burstiness:

a. Technical Review: Manufacturers must provide comprehensive technical documentation, encompassing detailed product specifications, manufacturing processes, quality control measures, and, if necessary, clinical trial data.

b. Clinical Evaluation: For devices with higher risk levels, it may be mandatory to conduct clinical trials to validate both their safety and efficacy. The design of these trials, patient selection criteria, and adherence to ethical guidelines must align with specific medical device regulations.

c. Quality System Certification: Manufacturers must acquire a quality system certification, such as the esteemed Good Manufacturing Practice (GMP) certification, which guarantees compliance with rigorous quality management standards.

  • Quality Management System:

In China, adherence to the Quality Management System (QMS) requirements is mandatory for medical device manufacturing. The QMS incorporates guidelines, such as Good Manufacturing Practice (GMP), which place significant emphasis on various aspects including quality control, risk management, traceability, and post-market surveillance. It is crucial for manufacturers to implement these QMS standards to ensure ongoing compliance with regulatory processes and mandates.

  • Unique Device Identification (UDI) System:

China has put into effect a unique device identification (UDI) system as a measure to bolster traceability and post-market surveillance of medical devices. Manufacturers are obligated to affix unique identification codes to their devices for the purpose of monitoring their distribution, usage, and reporting adverse events. By implementing the UDI system, the safety of medical devices is enhanced, and the effectiveness of recalls as well as the overall management of these devices is significantly improved.

  • Labeling Requirements:

Medical device labelling requirements are strict to ensure accurate and comprehensive information on product packaging. This includes essential details like device name, specifications, instructions for use, storage conditions, and potential risks or contraindications. All labelling should be in Chinese, and symbols or graphics must adhere to Chinese standards.

  • Clinical Trial Requirements:

In China, clinical trials play a crucial role in ensuring the safety and effectiveness of medical devices with higher risk levels. These trials are mandatory and are conducted to validate the efficacy of such devices. Manufacturers are responsible for designing and conducting these trials in accordance with specific guidelines set by the National Medical Products Administration (NMPA). Ethical considerations, patient recruitment criteria, trial design, and meticulous data analysis are all integral parts of these trials.

  • Testing Requirements:

To register medical devices in China, manufacturers must submit thorough technical documentation, including testing data. This data should prove that the device meets the safety and performance standards set by the NMPA. The documentation includes product specifications, manufacturing processes, quality control measures, and, when applicable, clinical trial results.

  • Foreign Testing and Applicable Countries:

When it comes to registering medical devices in China, the regulations are not explicit about whether foreign testing is acceptable. Manufacturers who want to register their devices in China should make sure to meet the domestic testing requirements and provide testing data that follows Chinese standards. This means conducting the necessary tests and providing the results in accordance with the specific protocols mandated by the Chinese regulatory authorities.

  • Pre-registration Requirements:

Before registering medical devices in China, manufacturers need to fulfil pre-registration requirements. This includes preparing comprehensive technical documentation, clinical trial data (if applicable), and obtaining quality system certification. It is essential to verify that the devices meet the classification criteria defined by the National Medical Products Administration (NMPA) and undergo a rigorous technical review and evaluation process. Compliance with these requirements is crucial for a successful registration process in China.

  • Import and Distribution Requirements for Medical Device Regulations in China:

Medical device import and distribution in China is subject to strict regulations set by the China Food and Drug Administration (CFDA). To comply with these regulations, it is mandatory to register the medical devices, providing detailed information about their features, intended use, manufacturing processes, and clinical data that demonstrate safety and effectiveness. For foreign manufacturers, it is essential to appoint a local agent in China who will facilitate communication with regulatory authorities. By adhering to these requirements, the import and distribution process for medical devices in China can proceed smoothly and in accordance with the necessary regulations.

  • List of Documents Required:

When it comes to registering medical devices in China, certain documents are necessary. These include a detailed device description, clinical data, manufacturing information, and product testing results, as well as translated labelling and user instructions in Chinese. Ensuring these documents are provided is crucial for a successful registration process in China's medical device market.

  • Timeline and Associated Fees:

In China, the regulatory process for medical devices varies depending on their classification. Class I devices require a notification process that typically takes 5 to 6 months. On the other hand, for Class II and Class III devices, registration is necessary and can take anywhere from 15 to 32 months. Additionally, manufacturers and distributors should be aware that government fees ranging from 210,900.00 RMB to 308,800.00 RMB are currently required for the registration of Class II and Class III Medical Devices.

  • Clinical Trials and Testing:

To ensure the safety and efficacy of Class II and Class III medical devices, clinical trials and testing are frequently mandated. The National Medical Products Administration (NMPA) in China has established comprehensive guidelines for conducting these clinical trials. These guidelines encompass crucial aspects such as patient recruitment, ethical considerations, trial design, and data analysis.

  • Post-Market Surveillance:

In order to closely monitor the safety and performance of medical devices, China has implemented an all-encompassing post-market surveillance system. Manufacturers are required to establish protocols for reporting adverse events, implementing product recalls, and conducting post-market studies. The National Medical Products Administration (NMPA) carries out periodic inspections and audits to ensure adherence to regulations and promptly addresses any risks that may arise to protect public health.


Manufacturers aiming to enter and thrive in the Chinese market must strictly abide by these regulations as they play a vital role in ensuring adherence to best practices and maintaining high standards for patient safety.


National Medical Products Administration. Medical Devices Regulations.

China Food and Drug Administration.Provisions for the Supervision and Administration of Medical Devices.

National Medical Products Administration.Technical Guidelines for the Clinical Evaluation of Medical Devices.

National Medical Products Administration.Guidance on the Application and Implementation


bottom of page